A Comparison of Fulvestrant Plus a Targeted Agent With Fulvestrant Alone in Hormone Receptor-Positive Advanced Breast Cancer That Progressed on Prior Endocrine Therapy: A Meta-Analysis
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s166653
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Informa UK Limited